SPECIMAN RESOURCE CORE
样本资源核心
基本信息
- 批准号:7901169
- 负责人:
- 金额:$ 23.15万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:
- 资助国家:美国
- 起止时间:至
- 项目状态:未结题
- 来源:
- 关键词:AddressAntibodiesBasic ScienceBioinformaticsCellsClinicalClinical TrialsComprehensive Cancer CenterComputer AnalysisDNADNA analysisDataDatabasesDevelopmentDiagnosisEnsureEpidemiologyImmunologyInstitutionLesionLinkLymphocyteMessenger RNAMutationNevi and MelanomasOligonucleotidesOperative Surgical ProceduresPharmaceutical PreparationsPlasmidsProceduresProteinsRNAReagentReproduction sporesResearch InfrastructureResearch PersonnelResourcesSerumServicesSkinSkin CancerSpecimenSystemTestingTissue Microarraychromatin modificationclinical practicecostfollow-upgenetic technologymeetingsmelanomaneoplastic cellnovelnovel strategiesprogramsresponsestatisticstranslational study
项目摘要
The Specimen Resource Core will use existing infrastructure to address the broad needs of translational
studies in two skin cancers that are not met by current specimen acquisition, diagnosis and distribution
shared facilities. The core will engage in collecting, storing and distribution of a wide range of specimens and
reagents, specimen analysis and reagent verification. In addition, it will develop new approaches for
multiplex specimen analysis, DNA and RNA extraction and amplification, comprehensive database systems,
and computational analysis. More specifically, the core will: a) build on and extend the current repertoire of
specimens for translational studies in skin cancers, including normal skin, melanocytic lesions, melanoma,
BCC, serum and circulating lymphocytes, ensuring their proper storage, annotation, and timely distribution to
SPORE investigators; b) coordinate the construction of nevi/melanoma tissue microarrays and test/cell
arrays; c) validate antibodies and TMA results; d) establish and maintain a central database program of
essential pathological, clinical, epidemiological, follow-up information and basic research data that will be
integrated with the bioinformatics/statistics core; e) provide special services such as the analysis of
specimens for clinical trials, mutations, chromatin modification, and responses to novel drugs; f) maintain
and distribute verified reagents (antibodies, oligonucleotides, DNA, RNA, plasmids, proteins) needed for
tumor and cell analyses; g) spearhead the development of new approaches for specimen diagnosis, such as
multiplex analysis of markers, isolation and amplification procedures for mRNA and DNA from scarce
specimens; and h) establish links with shared facilities at Yale and similar resources in other institutions,
including other SPOREs. This core will interact extensively with the Bioinformatics, Clinical Trial Office,
Immunology, Critical Technologies, and Genetics shared facilities of the Yale Comprehensive Cancer
Center. The services of the Specimen Resource Core will enhance the efficient operation of the translational
studies in the SPORE in a cost-effective manner, and expedite the application of discoveries at the bench to
clinical practice, and clinical results to basic research.
样本资源核心将利用现有的基础设施来满足翻译的广泛需求。
目前标本采集、诊断和分发不符合要求的两种皮肤癌研究
共享设施。该核心将从事收集、储存和分发各种标本,
试剂、样本分析和试剂验证。此外,它将制定新的方法,
多重样本分析、DNA和RNA提取和扩增、全面的数据库系统,
和计算分析。更具体地说,该核心将:
用于皮肤癌转化研究的标本,包括正常皮肤、黑色素细胞病变、黑色素瘤,
BCC、血清和循环淋巴细胞,确保其适当储存、注释和及时分发给
SPORE研究者; B)协调痣/黑素瘤组织微阵列的构建和测试/细胞
阵列; c)验证抗体和TMA结果; d)建立和维护一个中央数据库程序,
必要的病理学、临床、流行病学、随访信息和基础研究数据,
与生物信息学/统计学核心相结合; e)提供特殊服务,如分析
用于临床试验、突变、染色质修饰和对新药的反应的标本; f)维持
并分发所需的经验证的试剂(抗体、寡核苷酸、DNA、RNA、质粒、蛋白质),
肿瘤和细胞分析; g)率先开发新的标本诊断方法,例如
多重分析标记,分离和扩增程序的mRNA和DNA从稀缺的
标本; h)与耶鲁大学的共享设施和其他机构的类似资源建立联系,
包括其他孢子。该核心将与生物信息学,临床试验办公室,
免疫学,关键技术和遗传学共享耶鲁大学综合癌症中心的设施
中心标本资源中心的服务将提高翻译中心的有效运作,
以具有成本效益的方式在SPORE进行研究,并加快在实验台上应用发现,
临床实践和临床结果到基础研究。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
jennifer mcniff其他文献
jennifer mcniff的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('jennifer mcniff', 18)}}的其他基金
相似海外基金
University of Aberdeen and Vertebrate Antibodies Limited KTP 23_24 R1
阿伯丁大学和脊椎动物抗体有限公司 KTP 23_24 R1
- 批准号:
10073243 - 财政年份:2024
- 资助金额:
$ 23.15万 - 项目类别:
Knowledge Transfer Partnership
Role of Natural Antibodies and B1 cells in Fibroproliferative Lung Disease
天然抗体和 B1 细胞在纤维增生性肺病中的作用
- 批准号:
10752129 - 财政年份:2024
- 资助金额:
$ 23.15万 - 项目类别:
CAREER: Next-generation protease inhibitor discovery with chemically diversified antibodies
职业:利用化学多样化的抗体发现下一代蛋白酶抑制剂
- 批准号:
2339201 - 财政年份:2024
- 资助金额:
$ 23.15万 - 项目类别:
Continuing Grant
Isolation and characterisation of monoclonal antibodies for the treatment or prevention of antibiotic resistant Acinetobacter baumannii infections
用于治疗或预防抗生素耐药鲍曼不动杆菌感染的单克隆抗体的分离和表征
- 批准号:
MR/Y008693/1 - 财政年份:2024
- 资助金额:
$ 23.15万 - 项目类别:
Research Grant
Developing first-in-class aggregation-specific antibodies for a severe genetic neurological disease
开发针对严重遗传神经系统疾病的一流聚集特异性抗体
- 批准号:
10076445 - 财政年份:2023
- 资助金额:
$ 23.15万 - 项目类别:
Grant for R&D
Discovery of novel nodal antibodies in the central nervous system demyelinating diseases and elucidation of the mechanisms through an optic nerve demyelination model
发现中枢神经系统脱髓鞘疾病中的新型节点抗体并通过视神经脱髓鞘模型阐明其机制
- 批准号:
23K14783 - 财政年份:2023
- 资助金额:
$ 23.15万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Elucidation of the mechanisms controlling the physicochemical properties and functions of supercharged antibodies and development of their applications
阐明控制超电荷抗体的理化性质和功能的机制及其应用开发
- 批准号:
23KJ0394 - 财政年份:2023
- 资助金额:
$ 23.15万 - 项目类别:
Grant-in-Aid for JSPS Fellows
Role of antibodies in hepatitis E virus infection
抗体在戊型肝炎病毒感染中的作用
- 批准号:
10639161 - 财政年份:2023
- 资助金额:
$ 23.15万 - 项目类别:
Defining the protective or pathologic role of antibodies in Post-Ebola Syndrome
定义抗体在埃博拉后综合症中的保护或病理作用
- 批准号:
10752441 - 财政年份:2023
- 资助金额:
$ 23.15万 - 项目类别:
Human CMV monoclonal antibodies as therapeutics to inhibit virus infection and dissemination
人 CMV 单克隆抗体作为抑制病毒感染和传播的治疗药物
- 批准号:
10867639 - 财政年份:2023
- 资助金额:
$ 23.15万 - 项目类别:














{{item.name}}会员




